2016
DOI: 10.21037/atm.2016.06.02
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Background: Co-morbidity of primary lung cancer (LC) and heart disease (HD), both requiring surgical therapy, characterizes a high risk group of patients necessitating prompt diagnosis and treatment. The aim of this study is the review of available evidence guiding the management of these patients.Methods: Postoperative outcome of patients operated for primary LC (first meta-analysis) and for both primary LC and HD co-morbidity (second meta-analysis), were studied. Parameters examined in both meta-analyses wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
3
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 135 publications
(194 reference statements)
2
3
0
Order By: Relevance
“…The reoperation rate for bleeding was 0–11% for combined procedures and 0% for staged procedures. Similar to our results, a more recent systematic review and meta-analysis by Bablekos and co-workers included 22 retrospective studies from 1985 to 2011 [ 37 ]. They summarized the operative mortality rate, complication rate, and survival rate of lung cancer patients complicated with heart disease.…”
Section: Discussionsupporting
confidence: 87%
“…The reoperation rate for bleeding was 0–11% for combined procedures and 0% for staged procedures. Similar to our results, a more recent systematic review and meta-analysis by Bablekos and co-workers included 22 retrospective studies from 1985 to 2011 [ 37 ]. They summarized the operative mortality rate, complication rate, and survival rate of lung cancer patients complicated with heart disease.…”
Section: Discussionsupporting
confidence: 87%
“…The reoperation rate for bleeding of combined procedures was 0-11% and of staged procedures was 0%. Similar to our results, a more recent systematic review and meta-analysis by Bablekos and co-workers included 22 retrospective studies from 1985-2011 (37). They summarized the operative mortality rate, complication rate, and survival rate of lung cancer patients complicated with heart disease.…”
Section: Discussionsupporting
confidence: 77%
“…NSCLC is initiated from the non-small cells in the lung, and is the most common type of cancer worldwide ( 8 ). According to clinical statistical investigations into lung cancer, >80% of newly diagnosed patients are in the middle or severe stages of the disease ( 9 11 ).…”
Section: Introductionmentioning
confidence: 99%